Customized Proteomics Solutions for Expedited Drug Discovery
Proteomics studies can be applied to advance early- to mid-stage drug discovery and development efforts. From total proteome, to post-translational modification analysis, to signaling pathway elucidation, proteomics studies can increase effectiveness and decrease timelines for target/biomarker identification and understanding of mechanism of action and off-target effects.
Explore the full suite of customized proteomics solutions on the Proteomics Services page.
Presenter: Matthew P. Stokes, PhD, Associate Director, Proteomics and Services, Cell Signaling Technology.
This webinar is geared toward scientists focused on therapeutic discovery and development:
Your work in the discovery pipeline:
- Target Identification
- Screening
- Hit-to-lead
Challenges you may be facing:
- Time pressure to move candidates to the next stage
- Having to educate yourself on areas of biology you haven't (yet) studied
- Having sufficient data to make go/no-go decisions
- Ensuring the data you depend on is reproducible
What you'll learn:
- How to observe and interpret the behavior of thousands of proteins in your sample when treated with your compound
- The role of post-translational modifications in therapeutic response
- How proteomics data can help guide experimental design, assay development and biomarker discovery
- How to leverage external expertise in your discovery and development activity